Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for worsening outpatient heart failure
NCT02476409Phase 4Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jul 2015
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in heart failure (HF), sponsored by University of North Carolina at Chapel Hill. Started Jul 2015; status: completed.
02
Drugs
tolvaptan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02476409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02476409.